PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 36 filers reported holding PROTARA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315,069 | -30.1% | 188,664 | 0.0% | 0.04% | -47.2% |
| Q2 2023 | $450,907 | -22.9% | 188,664 | 0.0% | 0.07% | -45.9% |
| Q1 2023 | $584,859 | +15.7% | 188,664 | 0.0% | 0.13% | +9.0% |
| Q4 2022 | $505,619 | -9.4% | 188,664 | 0.0% | 0.12% | +9.9% |
| Q3 2022 | $558,000 | -26.2% | 188,664 | -26.8% | 0.11% | -19.6% |
| Q2 2022 | $756,000 | -50.1% | 257,853 | -13.0% | 0.14% | -30.7% |
| Q1 2022 | $1,515,000 | -19.6% | 296,426 | +6.1% | 0.20% | -29.2% |
| Q4 2021 | $1,885,000 | -43.2% | 279,256 | -41.8% | 0.28% | +20.1% |
| Q3 2021 | $3,321,000 | -41.7% | 479,995 | -17.9% | 0.23% | -49.1% |
| Q2 2021 | $5,696,000 | -44.3% | 584,804 | -10.0% | 0.46% | +33.7% |
| Q1 2021 | $10,223,000 | -35.0% | 649,542 | 0.0% | 0.34% | -50.4% |
| Q4 2020 | $15,725,000 | +29.3% | 649,542 | -10.1% | 0.69% | -21.2% |
| Q3 2020 | $12,158,000 | -21.5% | 722,443 | +36.8% | 0.88% | -28.6% |
| Q2 2020 | $15,480,000 | – | 527,964 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |